Welcome to our dedicated page for Willis Towers news (Ticker: WTW), a resource for investors and traders seeking the latest updates and insights on Willis Towers stock.
News about Willis Towers Watson Public Limited Company (WTW) reflects its role as a global advisory, broking and solutions company focused on people, risk and capital. Because WTW operates through its Health, Wealth & Career and Risk & Broking segments, its news flow spans employee benefits, pensions, insurance broking, risk analytics and technology for insurers.
On this page, readers can follow WTW news related to earnings announcements, capital markets activity, product launches and strategic transactions. Recent disclosures include plans to announce fourth quarter and full year financial results, the pricing of senior notes issued by Willis North America Inc. and guaranteed by WTW, and the entry into a revolving credit facility under a Third Amended and Restated Credit Agreement.
WTW also issues news about its Insurance Consulting and Technology offerings, such as the launch of Radar Fusion, an augmented underwriting technology, and the Radar Connector for Databricks, which integrates its Radar analytics platform with the Databricks Data Intelligence Platform. These updates illustrate how WTW uses data and analytics to support insurers with pricing, underwriting and governance.
In addition, WTW publishes research-driven releases, including its analysis of funded status for large U.S. corporate defined benefit pension plans and its Commercial Lines Insurance Pricing Survey (CLIPS), as well as political risk reports produced by Willis, a WTW business. Strategic news items also cover agreements to acquire Newfront and Cushon, subject to regulatory approvals and customary closing conditions.
Investors, clients and observers can use this news feed to monitor how WTW develops its advisory, broking and technology capabilities, how it approaches risk and capital management topics, and how its transactions and research initiatives may influence its position within the insurance agencies and brokerages industry.
Pacific Life has partnered with Wespath Benefits and Investments and WTW to introduce a qualifying longevity annuity contract (QLAC) as part of Wespath's LifeStage Retirement Income program. This new program offers participants an interactive retirement income modeling tool and an optional social security bridge alongside the QLAC, which guarantees income starting at age 80. This initiative aims to enhance lifetime income security for retirees and include tax planning options through reduced minimum distributions.
Willis Towers Watson (NASDAQ: WTW) announced a registered offering of $750 million in 4.650% senior unsecured notes due 2027. The offering is conducted by its subsidiary, Willis North America, with the company guaranteeing payments. The proceeds will be used primarily to repay about €540 million of 2.125% senior notes due 2022 and for general corporate purposes. The offering is expected to close on May 19, 2022, pending customary conditions.
WTW has initiated a new financial project aimed at bolstering the resilience of vulnerable fishing communities in Fiji and Papua New Guinea against climate change impacts. This initiative, titled Financial Tools for Small-scale Fishers in Melanesia, developed in collaboration with WWF, will create financial products that provide faster payouts to support these communities. The project is funded by the GEF’s Special Climate Change Fund, addressing the lack of climate risk protection beyond existing insurance policies.
WTW reported a 3% decrease in total revenue for Q1 2022 at $2.16 billion, despite organic growth of 2%. Diluted EPS fell 82% year-over-year to $1.03, while adjusted EPS rose 22% to $2.66. Income from operations declined to $179 million with an operating margin of 8.3%, down 120 bps. Significant share buybacks of $4.1 billion were executed. Enhanced hiring rate and focus on strategic initiatives are noted, with plans for mid-single digit organic revenue growth for 2022.
WTW (NASDAQ: WTW) announced the appointment of Michael Chang as Head of Corporate Risk and Broking (CRB) North America, effective later in 2022. He replaces Mike Liss, who will retire in mid-2023. Michael Chang brings over two decades of experience from Sompo International and Chubb, emphasizing industry specialization and a data-driven approach. Adam Garrard, Head of CRB, highlighted Chang’s global perspective and strong client connections as vital to WTW's strategy. Mike Liss's leadership over 16 years cultivated a strong business presence with 3,000 colleagues across North America.
Summary not available.
WTW (NASDAQ: WTW) has appointed Mike McKinley as the new Global Head of Tax, effective May 9. This move is part of a broader strategy to enhance the Finance function, coinciding with WTW's strategic priorities to grow, simplify, and transform operations. McKinley, previously with Marsh McLennan, brings over 25 years of experience in the industry. His leadership is expected to provide valuable insights and a fresh perspective, further driving WTW's mission of data-driven solutions across 140 countries.
WTW (NASDAQ: WTW) has been recognized for the 11th consecutive year in the IAOP's 2022 Global Outsourcing 100 list, highlighting its excellence as an outsourcing provider. WTW achieved top scores in Innovation and received accolades for Customer References, Corporate Social Responsibility, and Sustained Excellence. The recognition reflects WTW's commitment to delivering efficient solutions and exceptional employee experiences, with more than 140 countries serviced. This acknowledgment reinforces the company's focus on innovation and client success amidst evolving market demands.
Summary not available.
WTW has chosen Capital Rx as its innovative pharmacy benefits management (PBM) partner, aiming to provide clients with improved flexibility, transparency, and competitive drug pricing. This decision follows employers' frustrations over rising prescription drug costs. Capital Rx's model emphasizes transparency in drug pricing and offers significant financial value through its Clearinghouse Model®, designed to enhance cost visibility. Capital Rx's technology facilitates savings and increased efficiency for employers participating in the Rx Collaborative.